Amici FDA Monday, February 7, 2000 0.00 Neutral

FDA Approves BUPROPION HYDROCHLORIDE — Amici Pharma, Inc.

Amici Pharma's approval of its bupropion hydrochloride generic is expected to intensify competition within the oral antidepressant market, pressuring the branded version's pricing and market share.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day